MKTX vs STRO
MarketAxess Holdings Inc (MKTX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MKTX currently screens at market cap $4.00B and trailing P/E 13.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MKTX and STRO stock pages for the full models.
Not investment advice.